Viewing Study NCT00988832


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2026-03-27 @ 5:23 PM
Study NCT ID: NCT00988832
Status: COMPLETED
Last Update Posted: 2015-09-02
First Post: 2009-10-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Audit of Patients With Crohn's Disease Treated With Infliximab (P06066)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-02
Start Date Type: None
Primary Completion Date: 2010-12
Primary Completion Date Type: ACTUAL
Completion Date: 2010-12
Completion Date Type: ACTUAL
First Submit Date: 2009-10-01
First Submit QC Date: None
Study First Post Date: 2009-10-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2011-12-06
Results First Submit QC Date: None
Results First Post Date: 2012-07-26
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-09-01
Last Update Post Date: 2015-09-02
Last Update Post Date Type: ESTIMATED